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INTRODUCTION 
 
Natural world constantly stands as a golden mark to illustrate the exceptional 
phenomenon of symbiosis. Natural products from plant, animal and mineral source have been the 
basis of treatment for a variety of human diseases throughout the world. About 80 % of people in 
developing countries rely on traditional herbal medicines based mainly on species of plants and 
animals. Studies have showed that regarding 800 plants have been used in native systems of 
medicine.  
India is a measureless storehouse of medicinal plants that are used in traditional medical 
treatments. The various native systems such as Siddha, Ayurveda, Unani and Allopathy use 
several plant species to treat different ailments. Herbal medicines as a major remedy in 
traditional system of medicine have been used in medical practices since antiquity. The use of 
herbal medicines have become renowned due to increased toxicity and side effects produced by 
allopathic medicines that paved its way to a swift increase in the number of herbal drug 
manufacturers. The practice continues these days because of its biomedical reimbursement as 
well  as place in intellectual beliefs in many parts of world and has made a great input towards 
maintaining human health. In India around 20,000 medicinal plant species have been recorded 
newly but more than 500 traditional communities use about 800 plant species for curing diverse 
diseases. At present 80% of the world population depends on plant-derived medicine as the first 
line of principal health care for human mitigation due to no side effects. 25% of pharmaceutical 
prescriptions in the United States contain at least one plant-derived component. In the last 
century, roughly 121 pharmaceutical products were formulated based on the long-established 
information obtained from various sources. 
 
 HERBAL MEDICINES OBTAINED FROM PLANTS 
India has one of the richest plants medical traditions in the world. There are estimated to 
be around 25,000 effective plant-based formulations, used in folk medicine and known to rural 
communities in India. There are over 1.5 million practitioners of traditional medicinal system 
using medicinal plants in preventive, promotional and curative applications. It is estimated that 
there are over 7800 medicinal drug-manufacturing units in India, which consume about 2000 
tonnes of herbs annually. 
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 MARKET VALUE OF HERBAL MEDICINES 
For ayurvedic medicine, the demand is estimated to be expanding at a rate of 20% yearly. 
The sales of medicinal plants have grown-up by nearly 25% in India in past ten years (1987-96), 
the highest rate of growth in the world. But the per capita expenses in India on medicines per 
annum is amongst the lowest in the world. The largest users of medicinal plants are China and 
India. Conventional Chinese Medicine uses over 5000 plant species; India uses about 7000. 
According to Export Import Bank, the international market for medicinal plant related trade 
having a growth rate of 7% per annum. China’s share in world herbal market is US$ 6 billion 
and  India’s share is only US$1 billion. The yearly export of medicinal plants from India is 
valued at Rs. 1200 million. All the main herbal-based pharmaceutical companies are showing a 
constant growth of about 15 per cent. Conventional medicine has served as a source of 
alternative medicine, new pharmaceuticals, and healthcare products. Medicinal plants are 
important for pharmacological research and drug development, not only when plant constituents 
are used directly as therapeutic agents, but also as preparatory materials for the synthesis of 
drugs or as models for pharmacologically active compounds. A considerable number of modern 
pharmaceutical drugs are derived from medicinal plants. The derivatives of medicinal plants are 
non-narcotic with little or no side effects. 
 
 FUTURE PROSPECTS OF HERBAL MEDICINE MARKET 
Almost three fourths of the herbal drugs used worldwide were discovered following leads 
from local medicine. According to World Health Organization (WHO), about 25% of modern 
medicines are descended from traditionally used plants. Several others were synthetic analogues 
built on prototype compounds isolated from plants. Almost, 70% of current medicines in India 
are derived from natural products. The essential uses of plants in medicine will continue in the 
future, as a source of therapeutic agents, and as raw material base for the extraction of semi-
synthetic chemical compounds such as cosmetics, perfumes and food industries. Reputation of 
healthcare plant-derived products has been traced to their increasing acceptance and use in the 
cosmetic industry as well as to increasing public costs in the daily maintenance of personal 
health and well being. In the twin role as a source of healthcare and income, medicinal plants 
make an important contribution to the larger development process. Though the effectiveness of 
herbal requires development of quality perception in respect of the evaluation related evidences, 
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supplying the demand for botanicals and herbals is a booming business. In recent times even 
developed countries, have implemented the use of herbal drugs and remedies which 
unquestionably increased the demand for plant derived products worldwide. This means that 
scientists, doctors and pharmaceutical companies will be looking at countries like China, India, 
etc. for their necessities, as they have the most number of medicinal plant species and are the top 
exporters of medicinal plants. 
 
 FUTURE INVESTIGATION OF TRIBAL MEDICINES 
The tribal healers in most of the countries, where ethno-medical healing is frequently 
used to treat cut wounds, skin infection, swelling, aging, mental illness, cancer, asthma, diabetes, 
jaundice, scabies, eczema, venereal diseases, snakebite and gastric ulcer, provide instructions to 
local people as how to prepare medicine from herbal. They keep no report and the information is 
mainly passed on vocally from generation to generation. World Health Organization (WHO) has 
shown great attention in documenting the use of medicinal plants used by tribals from different 
parts of the world. Various developing countries have intensified their efforts in documenting the 
ethno-medical data on medicinal plants. Investigation to find out scientific evidence for claims 
by tribal healers on Indian herbs has been intensified. Once these local ethno-medical 
preparations are systematically evaluated and disseminated properly, people will be better 
informed regarding efficacious drug treatment and improved health status. 
 
 ALLOPATHIC SYSTEM OF MEDICINE 
Allopathic system refers to the practice of usual medicine that uses physiologically active 
agents or physical interventions to treat or contain the symptoms or patho-physiologic processes 
of diseases or conditions. It was coined by Samuel Hahnemann (1755–1843) a homeopath, in 
1810. Allopathic medicine often refers to "the broad category of medical practice that is so called 
Western medicine, bio-medicine, evidence-based medicine, or modern medicine".  
 
 TRADITIONAL SYSTEM OF MEDICINE 
For  the human beings disease threatens not only the well being of victims and their 
fellows, but also the integrity of the society. Illness and death are troublesome events that impose 
high economic, social and psychological costs wherever they occur. For that reason it is of 
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primary significance to the members of every group to try to maintain their health and to restore 
to health those who fall ill.  
All  human society has responded to this challenge by developing a medical system that 
can be used to restore health. A system of medicine or medical organization can be defined as the 
pattern of social institution and cultural traditions that evolved from purposeful behavior to 
enhance health. Numerous traditional medical systems exist along with present-day scientific 
medicine system. The available accounts of world’s medical system make the subject matter of 
ethno-medicine which is concerned with the beliefs and practices connecting to disease that are 
products of aboriginal cultural developments and are not derived from conceptual framework of 
modern medicine. 
 
 AYURVEDA INDIAN SYSTEM OF MEDICINE 
The Ayurvedic system originated in India long back in pre-vedic era from Vedas, which 
is the most ancient manuscript and gives more information on the health and diseases than any 
other documented information. Ayurveda born out of instinct and revelation, developed in due 
course into a complete system of medicine. The term Ayurveda means ‘Science of Life’. The 
basic theories of Ayurveda arise from the conception of Tridosha that embraces the process of 
creation and evolution of Universe and laws of life. The function of the body is considered to be 
the harmonizing work of body, sense organs, mind and soul. These are classified into Vata, Pitta 
and Kapha. These correspond principally to elements of air, fire and water. 
 The body consist of seven Dhatus or tissues . These are: Rasa- body fluids, Rakta- 
blood, Mansa-muscular tissue, Meda- adipose tissue, Asthi- bone tissue, Majja- nerve tissue and 
bone marrow, and Shukra- generative tissue. There are also waste products (Malas). There are 
many malas in the body- stool, urine, sweat, nails, hair etc. Health depends on balanced state of 
all dhatus, doshas and malas both in quantity and quality. According to Ayurveda all objects in 
the universe including human body are composed of five basic elements called 
Panchamahabhutas  namely, earth, water, fire, air and sky. 
 
 UNANI SYSTEM OF MEDICINE 
The Unani system of medicine may be traced to that system of Greek medicine that was 
developed during the Arab civilization. It was the Greek philosopher-physician Hippocrates on 
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whose teachings the theoretical structure of medicine is based. After him a number of other 
Greek scholars enriched the system noticeably. Of them Galen stands out as the one who 
stabilized its underpinning, on which Arab physicians like Razes and Avicenna constructed the 
imposing edifice. It is now practiced in the Indo-Pakistan subcontinent after being introduced by 
Arabs. The basic viewpoint of Tibb is that the body is composed of matter and spirit. Human 
body is taken as a entirety because pleasant-sounding life is possible only if there is a proper 
equilibrium between bodily and spiritual functions. 
The fundamental agenda consists of theory of Hippocrates, which presupposes the 
presence of four humours in the body namely blood, phlegm, yellow bile and black bile. 
According to prehistoric percepts of Unani theory, there are four primary elements namely Nar 
or fire, Hawah or air, Ma or water and Arz or earth. This is a generally accepted theory among all 
schools of thoughts of Unani medicine. Air stands for gaseous state, water for liquid state, earth 
for solid state while fire stands for matters that has been transformed into heat. The properties of 
these four elements are: Nar- hot and dry, Hawah-hot and wet, Ma-cold and wet and Arz-cold 
and dry. 
The prehistoric Unani scholars based their study on the hypothesis of humours which 
combined both physiology and pathology. According to them there are three types of matter in 
the human body namely solid, liquid and gas. Solid parts are known as organs or A’da, liquid 
parts are known as humours or Akhlat and the gaseous parts are known as pneuma or Ruh. The 
body fluids, which are humours, are further sub-divided into four types: Dam (Blood), Balgham 
(Phlegm), Safra (Yellow bile) and Sauda (Black bile). On the basis of different constitution, 
people can be categorized under four basic temperaments. The four are damwi, bilious, 
phlegmatic and melancholic temperament. 
 
 HOMEOPATHIC SYSTEM OF MEDICINE 
This system of medicine is  a  authority whose primary emphasis is on therapeutics. It is a low 
cost system employing entirely non toxic drugs. This system derives its name from two Greek 
words Homoios (like) and Pathos (treatment). Homoeopathic system of medicine was started by 
the chemist, physician and pharmacist Samuel Hahnemann of Germany. He promoted the law of 
similar which says that like cures like. 
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Homoeopathy is the system of healing based on scientific methods and demonstrable laws and 
principles, which are –Law of Similars, Law of Direction of Cure, Law of Single Remedy, Law 
of Minimum Dose. Homoeopathic medicines are used in the form of mother tinctures, small 
pills, powders and distilled water. 
 
 NATUROPATHY AND YOGA 
Until  the recent past, Yoga was considered very exotic and secret, being a forte of the 
hermits and saints who trained it in aloofness to attain spiritual clarification. The word "Yoga " is 
derived from the root "Yujir Yoge ", which means "to unite" or "to bind" or "to yoke". 
According to Yajnavalkya, Yoga means "the Union" i.e. combination of the individual spirit 
(Jivatman) with the universal spirit (Parmatman). The word "Yoga" is derived from the root "Yuj 
Samadhau" meaning spiritual incorporation. According to Bhagwad Gita, the word Yoga means 
"Equanimity of Mind", which can only be acquired after getting recognized in discriminative 
wisdom (which is a consequent of strong meditation). While according to Maharishi Patanjali, 
Yoga is defined as the "cessation of modifications of Chitta, which results into individual soul 
enduring in itself and thereby attaining God Realization and Spiritual perfection." The system of 
Yoga is more than 5000 years old and Gita has rightly described it as ancient (Puratan) and 
eternal (Sanatan). 
 
 HERBAL MEDICINE 
Herbal remedy, or  phytotherapy  , is the science of using herbal drus to treat the sick. 
The term was introduced by the French physician Henri Leclerc (1870-1955). He had published 
several essays on the use of medicinal plants, most of them in La Presse Medicale, a leading 
French medical journal. These essays were exceptional for their style, and splendid examples of 
the art of presenting a subject. He summed up his life-time knowledge in Pr&s de Phytothkrapie, 
a brief work that has since become a classic. Herbal medicine has move toward a long way since 
the days of the ancient ‘herbalism’. The study of the use of medicinal plants is now a scientific 
subject, a branch of medicine in the same way as chemotherapy, hydrotherapy, electrotherapy 
and others. Information of medicinal plants and their uses has been recorded from antiquity - by 
Imhotep, the priest-physician of ancient Egypt who devised the Step Pyramid of Sakkara, by 
Galen, personal physician to the Roman emperor Marcus Aurelius, and later by Paracelsus, the 
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Abbess Hildegard of Bingen, and the authors of the great herbals of medieval times, exact to the 
present day.
45,46 
 
DIABETES MELLITUS 
     Pancreas has both endocrine and exocrine functions. The exocrine functions are largely the     
digestive enzymes. Speckled among the exocrine portion of the pancreas are millions of tiny 
clusters of endocrine tissue called pancreatic islets or islets of Langerhans, which contains four    
types of cells secreting different hormones. 
 Alpha cells: 
   Constitutes about 20% and secrete glucagon, which raises blood glucose level. 
 Beta cells: 
  Constitutes about 75% and insulin which lowers blood glucose level. 
 Delta cells: 
  Constitutes about 3% and secrete growth hormone release inhibiting hormone or somatostatin. 
 Pp cells: 
  Constitutes about 2% and secrete pancreatic polypeptide which regulates the release of 
pancreatic digestive enzymes. 
 
 
 
 
                                                        Fig 1: Structure of Insulin 
 
 
It is composed of two chains (chain-A of 21 and chain-B of 30 amino acids) that are joined 
mutually by disulfide cross-bridges. 
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 MECHANISM OF ACTION 
The insulin receptor in mammalian cells is a huge trans-membrane glycoprotein. It is 
composed of two α-subunits and two β-subunits linked by disulfide bonds to comprise a β-α-α-β 
heteroteramer. β-subunits contain tyrosine residues. When insulin binds to the α- subunit at the 
exterior of the cell surface, the tyrosine kinase activity, in β subunits is stimulated. Insulin in 
addition stimulates the glucose transport across cell membrane by ATP-dependent translocation 
of glucose transporter-4(GlUT_4) to the plasma membrane, an event that is vital for glucose 
uptake by skeletal muscle and fat.  
 
 
 
Fig 2: Mechanism of Insulin 
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Fig 3: Actions of  Insulin 
 
The word diabetes mellitus describes a metabolic disorder of numerous etiology 
characterized by chronic hyperglycemia with instability of carbohydrate, fat and protein 
metabolism resulting from defects in insulin secretion, insulin action, or both. The word 
“diabetes” stems from a Greek term for passing through, a location to increased urination 
(polyuria), a common symptom of the disease. “Mellitus” is the Latin word for honeyed, a 
indication to glucose noted in the urine of diabetic patients. Diabetes mellitus is sometimes 
referred to as sugar diabetes but as a rule is basically called diabetes. There is also a rare disease 
called diabetes insipidus (water diabetes) in which the kidneys release excessive water. Similar 
to diabetes mellitus, it has excessive urination as a symptom. The effects of diabetes mellitus 
include long–term damage, dysfunction and failure of various organs. Diabetes mellitus may 
present with typical symptoms such as thirst, polyuria, polydypsia, blurring of vision, and weight 
loss. In its most severe forms, ketoacidosis or a non–ketotic hyperosmolar state may develop and 
direct to stupor, coma and, in absence of effective treatment, death. Often symptoms are not 
relentless, or may be absent, and consequently hyperglycemia sufficient to cause pathological 
and functional changes may be present for a extended time before the diagnosis is made. The 
lengthy–episode of diabetes mellitus include progressive development of the specific 
complications of retinopathy with potential blindness, nephropathy that may lead to renal failure, 
and/or neuropathy with risk of foot ulcers, amputation, Charcot joints, and features of autonomic 
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dysfunction, including sexual dysfunction. People with diabetes are at increased risk of 
cardiovascular, peripheral vascular and cerebrovascular disease. 
 
 ROOT CAUSES OF DIABETES MELLITUS (DM) 
            The origin of diabetes is complex. Most cases begin with one of two processes: 
 METABOLIC 
Detrimental lifestyle factors such as overeating, physical inactivity and obesity can 
weaken the body’s ability to use insulin. This is called insulin resistance. Unmanageable risk 
factors including genetics, family history and age can also be involved. Metabolic forms of 
diabetes include: 
1. Type 2 diabetes 
This accounts for 90 - 95% of diabetic cases, according to the U.S. National Institutes of 
Health (NIH). Some of these patients have had prediabetes that went uncontrolled. Once thought 
as a disease of middle and old age, type 2 is also becoming more widespread in youths as the 
incidence of childhood obesity grows. 
2. Gestational diabetes 
Changes in hormone level contribute to this condition which can develop in any 
previously nondiabetic woman during pregnancy, especially those who are overweight. 
 
 FACTORS CONTRIBUTING DIABETES MELLITUS 
Diabetes involves chronic levels of unusually high glucose (hyperglycemia). Many 
patients, especially those with type 2 diabetes; also have high blood pressure (hypertension), 
chronic high levels of insulin (hyperinsulinemia) and unhealthy levels of cholesterol and other 
blood fats (hyperlipidemia). All of these factors contribute to the long-term complications of 
diabetes, which include: 
 Vascular disease (diabetic angiopathy), atherosclerosis, heart conditions and stroke 
           The cardiovascular disorders are the leading reason of death in people with diabetes. 
 Kidney disease (diabetic nephropathy) 
           Diabetes is the chief cause of end-stage renal disease, which requires treatment with 
dialysis or a kidney transplant. 
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 Eye diseases 
These comprise diabetic retinopathy, glaucoma and cataracts. Diabetes is a foremost 
cause of visual impairment and blindness. 
 Nerve damage (diabetic neuropathy) 
 Includes peripheral neuropathy, which often causes pain or numbness in the limbs, and 
autonomic neuropathy, which  can hinder digestion (gastroparesis) and contribute to sexual 
dysfunction and incontinence. Neuropathy may also damage hearing and other senses. 
 Impaired thinking 
Many studies have related diabetes to increased risk of memory loss, dementia, 
Alzheimer’s disease and other cognitive deficits. Recently some researchers have suggested that 
Alzheimer’s disease might be type 3 diabetes, involving insulin resistance in the brain. 
 Infections and wounds 
Conditions of foot and skin disorders, such as ulcers, make diabetes the leading cause of 
nontraumatic foot and leg amputations. People with diabetes are also prone to infection including 
periodontal disease, thrush, urinary tract infections and yeast infections. 
 Cancer 
Diabetes increases the threat of malignant tumors in the colon, pancreas, liver and several 
other organs. 
 Musculoskeletal disorders 
Several conditions ranging from gout to osteoporosis to restless legs syndrome to 
myofascial pain syndrome are more common in diabetic patients than nondiabetics. 
 Pregnancy complications 
Diabetes increases the risk of preeclampsia, miscarriage, stillbirth and birth defects. 
 Emotional difficulties 
Several but not all of the studies exploring connections between diabetes and mental 
illness have found increased rates of depression, anxiety and other psychological disorders in 
diabetic patients. In addition to chronic hyperglycemia, diabetic patients can experience acute 
episodes of hyperglycemia (High glucose) as well as hypoglycemia (low glucose). Severe cases 
can cause seizures, brain damage and a potentially fatal diabetic coma. Acute glucose 
emergencies include: 
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 Insulin shock: 
This complex stage of hypoglycemia is usually due to excessive amounts of insulin 
medication or certain antidiabetic agents. 
 Diabetic ketoacidosis: 
A lack of insulin can compel the body to burn fats instead of glucose for energy. The 
outcome is a toxic byproduct called ketones, along with severe hyperglycemia. 
 Hyperosmolar hyperglycemic non-ketotic state 
            This involves severe hyperglycemia and dehydration. 
 
 TYPES AND DIFFERENCES OF DIABETES 
            There are quite a lot of forms of diabetes. 
 Type 1 diabetes: 
Type-1 diabetes is an autoimmune disease in which the immune system erroneously 
destroys the insulin-making beta cells of the pancreas. It typically develops more quickly than 
other forms of diabetes. It is typically diagnosed in children and adolescents, and sometimes in 
young adults. Type 1 diabetes is also called as juvenile onset diabetes and insulin-dependent 
diabetes mellitus (IDDM). 
  A variant of type 1 that develops later in life, usually after age 30, called as latent 
autoimmune diabetes of adulthood (LADA). Sometimes patients with autoimmune diabetes 
develop insulin resistance because of weight gain or genetic factors. This condition is identified 
as double diabetes. 
 Type 2 diabetes: 
In the patients with type-2 diabetes , the pancreas makes insulin initially, but the body has 
difficulty using this glucose-controlling hormone. Ultimately the pancreas cannot produce 
enough insulin to react to the body’s need for it. It accounts for 85 to 95% of the cases. Type 2 
diabetes used to be called adult-onset diabetes and non-insulin-dependent diabetes mellitus 
(NIDDM). 
 Gestational diabetes:  
A temporary  metabolic  disorder that any formerly non-diabetic woman can develop 
during pregnancy, usually the third trimester. Hormonal changes contribute to this disease, 
beside with excess weight and family history of diabetes. About 4% of pregnant women develop 
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gestational diabetes, according to the American Diabetes Association. Gestational diabetes can 
cause harms for the mother and baby, together with preeclampsia, premature deli-very, 
macrosomia (oversized infant), and jaundice and breathing difficulties in the infant. This disease 
typically ends when the pregnancy does, but it increases the danger of type 2 diabetes later in life 
for the mother and the child. 
 Secondary diabetes: 
Diabetes caused through another condition. The many possible sources of secondary 
diabetes range from diseases such as pancreatitis, cystic fibrosis, Down syndrome and 
hemochromatosis to medical treatments including corticosteroids, other immune suppressives, 
diuretics and pancreatectomy. 
Maturity-onset   diabetes of the young (MODY). An unusual disease caused by a genetic 
defect inherited from a parent. It is generally diagnosed before age 25 in people of normal 
weight. MODY is sometimes classified as a form of type 2 or secondary diabetes but is often 
considered a separate form. 
There are also rare syndromes (clusters of conditions) that include diabetes, notably: 
 Wolfram syndrome 
Genetic   disorder that involves insulin-dependent diabetes, vision problems, deafness 
and diabetes insipidus. 
 Autoimmune polyglandular syndrome (APS) 
Are group of autoimmune endocrine diseases. Two of the three forms of APS feature 
type 1 diabetes. Unsteady diabetes, also known as brittle or labile diabetes, is a term that may be 
used to describe any case of poorly controlled diabetes despite of the type. All of these 
conditions involve diabetes mellitus (“sugar diabetes”). Diabetes insipidus (“water diabetes”) is 
an unrelated endocrine system disorder in which the kidneys release a large amount water.  
 
 RISK FACTORS AND CAUSES OF DIABETES 
The causes of diabetes are complex and only partially understood. This disease is 
generally well thought-out as multi-factorial,  connecting  to several predisposing conditions and 
risk factors. In many cases genetics, habits and environment may all contribute to a person’s 
diabetes. Other diabetic risk factors and causes include: 
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 Genetics and family history 
Certain genes are also known to cause maturity-onset diabetes of the young (MODY) and 
Wolfram syndrome. Genes also contribute to other forms of diabetes, including types 1 and 2. 
 Family medical history is also significant to varying degrees 
For instance, a person whose parents both have type 1 diabetes has a 10 to 25% chance of 
developing that disease, according to the American Diabetes Association, and someone whose 
parents both have type 2 diabetes has a 50% chance of developing that disease. 
 Weight and body type 
Overweight and obesity are foremost factors in type 2 diabetes and gestational diabetes. 
Excess fat, especially around the stomach (central obesity), promotes insulin resistance and 
metabolic syndrome. 
 Sex 
Low testosterone levels (male hypogonadism), which scientists have associated with 
insulin resistance. 
 Height of physical activity 
Lack of standard exercise is responsible for much of the twin global epidemics of obesity 
and diabetes. 
 Diet 
The outcome of diet in the development of diabetes is controversial. Some studies have 
related heavy consumption of soft drinks and other simple carbohydrates to risk of metabolic 
diabetes,  and foods with little glycemic index, such as whole grains, to reduced risk. 
 
 Other diseases 
Medical situations including high blood pressure, hyperlipidemia (unhealthy levels of 
cholesterol), polycystic ovarian syndrome, asthma and sleep apnea have been linked to type 2 
diabetes . Celiac disease (gluten intolerance) and other autoimmune diseases have been linked to 
type 1. Some conditions that may cause secondary diabetes include pancreatitis, 
hemochromatosis, endocrine disorders including hyperthyroiddism, Cushing’s disease and 
acromegaly, and genetic conditions including cystic fibrosis, Down syndrome and some forms of 
muscular dystrophy, Diabetic foot and urinary tract infection. 
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 Hormones 
Hormones are  the chemical messengers  that can contribute to diabetes in various ways. 
For example, stress hormones such as cortisol have been associated with   fluctuating glucose 
levels in type 2 diabetes, and stress hormones in women during pregnancy have been linked to 
risk of type 1 diabetes in the child. The release of growth and sex hormones during adolescence 
may make some teens more prone to diabetes. A broad range of hormonal treatments including 
anabolic steroids, growth hormone, estrogens, injected contraceptives, androgen deprivation 
therapy for prostate cancer and corticosteroids have been related with  secondary diabetes. 
 Medical treatments 
In addition to hormonal therapies, drugs  including diuretics, beta blockers (another class 
of antihypertensives), immunosuppressives, antiretrovirals (AIDS/HIV drugs) antipsychotics, 
lithium, and some antidepressants, anticonvulsants and chemotherapy drugs have been related to 
an increased threat of secondary diabetes. Pancreatectomy and radiation therapy may also result 
in secondary diabetes. Drugs including pentamidine (used to treat pneumonia) and L–
asparaginase k(used to treat leukemia) have been linked to type 1 diabetes. 
 Other chemicals 
In addition to the pharmaceuticals, some studies have associated PCBs, other pollutants 
and certain pesticides including the defoliant Agent Orange and Dioxin (its active ingredient) to 
insulin resistance and type 2 diabetes. General consumer plastics and plastics ingredients 
including Phthalates and Bisphenol A have also been linked to insulin resistance in some cases. 
Exposure to agricultural pesticides during pregnancy has been tentatively connected to 
gestational diabetes. A rat poison called pyriminal has been linked to type 1 diabetes. 
 Other environmental factors 
Researchers   hypothesize  that free radicals may add to the development of type 1 and 
possibly other forms of diabetes. Free radicals are produced as a result of chemical reactions in 
the body. Smoke, air pollution and even genetics contribute to the formation of free radicals. 
Once these radicals build up, they can destroy cells, plus those concerned in the production of 
insulin. Cold weather is another likely environmental factor in type 1 diabetes. This disease 
occurs most commonly in cold climates and develops more repeatedly in the winter than the 
summer. 
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 Viruses 
Some people are diagnosed with type 1 diabetes following a viral infection. Viruses 
thought to be related to type 1 diabetes consist of mumps, rubella and coxsackie virus (related to 
the virus family that causes polio and hepatitis). 
 Smoking 
Cigarette smoking is a risk factor for type 2 diabetes and possibly other forms of diabetes. 
 Alcohol 
Too much use of alcohol is a risk factor for diabetes. For instance, it can cause pancreatitis. But, 
some research has establish that light drinking may decrease the risk of becoming diabetic. 
 Signs and symptoms of diabetes 
- Extreme thirst (polydipsia) 
- Excessive urination (polyuria) and dehydration 
- Extreme hunger or appetite (polyphagia) 
- Mysterious weight loss 
- Blurred vision, nearsightedness or other vision problems 
- Recurrent infections, including skin infections, thrush, gingivitis, urinary tract infections and 
yeast infections 
- Slow healing of sores 
- Skin problems, such as itchiness or acanthosis nigricans 
- Fatigue, lethargy or drowsiness 
- Shakiness or trembling 
- Mood swings or irritability 
- Dizziness or fainting 
- Numbness, tingling or pain in the feet, legs or hands 
Type 1 diabetes can build up rapidly and often occurs after a disease, but symptoms may 
be mistaken for the flu or other general conditions. Type 2 diabetes can take several years to 
develop and sometimes becomes obvious only after long-term complications transpire, such as 
sexual dysfunction or leg pain that is due to diabetic neuropathy or claudication (caused by 
peripheral artery disease). 
Some people, particularly young people with type 1 diabetes, go undiagnosed until they 
are brought to a hospital with a crisis called diabetic ketoacidosis . Indicators of diabetic 
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ketoacidosis comprise sweet fruity-smelling or wine-smelling breath, confusion and heavy 
labored breathing (Kussmaul breathing). Sometimes patients are diagnosed with diabetes only 
after suffering other severe complications including insulin shock, hyperosmolar hyperglycemic 
non-ketotic syndrome or diabetic coma. To help prevent such complications, people are advised 
to undergo intermittent screening for diabetes with glucose tests, particularly if they have risk 
factors. 
DIAGNOSIS METHODS FOR DIABETES: 
Physicians employ glucose tests to diagnose diabetes. These blood tests determine the 
level of glucose (blood sugar) in a person’s bloodstream. Often when people have a physical 
assessment they are screened for diabetes with a fasting plasma glucose test (FPG). An FPG is 
regularly performed in the morning since this makes it easier for the patient to fast for the 
required eight hours. Glucose is measured in milligrams per deciliter (mg/dl) of blood. FPG 
results below 100 mg/dl are normal. Glucose between 100 and 125 mg/dl is considered pre-
diabetes. Glucose above 125 mg/dl indicates diabetes. To prove diagnosis, another glucose test 
must be performed on another day, according to the National Institute of Diabetes and Digestive 
and Kidney Disorders. If glucose testing determines that a patient has diabetes, further tests may 
be offered to ascertain the type.  
 
 
 
Fig 4: Schematic diagram for diagnosis 
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TREATMENT OPTIONS FOR DIABETES: 
The various forms of insulin administration include syringe injections, insulin pumps, insulin 
pens, jet injectors and inhaled insulin. Oral diabetes medications include: 
i) Alpha-glucosidase inhibitors 
ii) Biguanides 
iii) Meglitinides 
iv) Sulfonylureas 
v) Thiazolidinediones 
vi) A new class called DPP-4 inhibitors 
      Other important aspects of treating and monitoring diabetes include: 
i) Nutrition counseling 
ii) Every day foot care and skin care 
iii) Normal physical examinations and foot examinations 
iv) Usual blood pressure readings and cholesterol tests 
v)  A pneumonia vaccination and yearly flu shots. 
vi)  A sick-day plan devised by a physician. 
vii) Supplementary   medical care before, during and after pregnancy. 
viii) Cardiac and neurological testing as desired. 
Following the care plan can help avoid overwhelming diabetic complications such as leg 
amputation, blindness, heart attack, stroke and chronic kidney failure. 
 
PREVENTION METHODS FOR DIABETES 
There is no recognized way of preventing autoimmune forms of diabetes (type 1 and 
latent autoimmune diabetes of middle age) or genetic conditions such as maturity-onset diabetes 
of the young and Wolfram disease. Genetic tests can tell who is in danger, and clinical trials are 
investigating probable methods of preventing type 1, including vaccines and pre-emptive use of 
insulin. People can take numerous steps to decrease their risk of developing metabolic forms of 
diabetes (type 2 and gestational diabetes). The principal focus is on managing weight during 
regular exercise and a reasonable diet. Such practices also help out people with other forms of 
diabetes circumvent insulin resistance and double diabetes. It is also advantageous to control 
blood pressure and cholesterol, avoid smoking and restrict alcohol. People with risk factors for 
CHAPTER-1                                                                                                                         INTRODUCTION 
 
Department of Pharmaceutical Chemistry, Nandha College Of Pharmacy, Erode Page 19 
 
diabetes must be screened regularly with glucose tests. Early detection and treatment can ward 
off many diabetic complications. 
 
ORAL HYPOGLYCAEMIC AGENTS:  
Are the used to treat type-2 diabetes and they have the prospective to decrease blood glucose to 
subnormal levels and also help insulin release from pancreatic β-cells. There are two classes of 
oral hypoglycaemic agents: sulfonylureas and meglitinides. 
1. Sulfonylureas: 
1.1.First generation:        Tolbutamide, chlorpropamide 
1.2.Second generation:   Glibenclamide, Glipizide, Gliclazide, Glimepiride 
The Sulfonylureas largely exert their action on β-cells, stimulating insulin secretion and 
thus dropping blood glucose levels. These drugs diminish the permeability of k
+
 by 
competitively blocking the sulfonylurea receptors present on ATP-sensitive k
+
 channels, causing 
depolarization, ca
2+
 entry and insulin secretion. 
2. Biguanides: Metformin: 
Their major action is to inhibit the neoglucogenesis and decrease the hepatic glucose output. 
They in addition increase the peripheral glucose utilization by improving anerobic glycolysis. 
They raise the sensitivity of peripheral tissues to insulin. 
3. Meglitinide Analogues: Repaglinide, Nateglinide. 
They act by subsequent mechanisms:1, Improved uptake and utilization of glucose by skeletal 
muscles, which reduces insulin resistance 2, Inhibition of hepatic as well as renal 
gluconeogenesis 3, Slows down glucose absorption from GIT which increases availability of 
glucose for its alteration to lactate by enterocytes 4, Promotion of insulin binding to its receptors 
and reduction in plasma glucagon levels. 
4. α-Glucosidase inhibitors: acarbose, miglitol  
            These are competitive inhibitors of intestinal  α-glucosidases. Acarbose also inhibits α-
amylase. Thus, these drugs diminish post-prandial digestion and absorption of carbohydrates and 
thus lower postmeal hyperglycaemia. 
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5. Thiazolidinediones(Glitazones): rosiglitazone, pioglitazone. 
 The Glitazones work as agonist to a nuclear receptor called Peroxisome Proliferator-
Activated Receptor-gamma (PPAR-γ), which makes a complex with retinoid-X Receptor (RXR). 
This activation mediate differentiation of adipocytes, increases lipogenesis and promotes uptake 
of fatty acids and glucose.
5, 7 ,53 
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LITERATURE REVIEW 
1.Guang-Zhi Zeng et al., (2009). Apoptosis inducement of bigelovin from extracts of Inula 
helianthus-aquatica on human leukemia U937 cells. Phytotherapy Research, volume 23,issue 
6, pages 885–891, June 2009.  Anti-leukemic activity of Inula helianthus-aquatica  is due to 
the presence of a  sesquiterpene lactone called Bigelovine. Bigelovin, a sesquiterpene lactone 
isolated  from Inula helianthus aquatica potentially inhibits the growth of a panel of eight 
cancer cell lines, especially in human monoblastic leukemia U937 cells with an IC(50) value 
of 0.47 microM. 
 
2. Fenglin Li et al., (2009). Preparation and antidiabetic activity of polysaccaharide from 
Portulaca oleracea L. African J Biotech, volume 8, issue 4, pages 569-573, Feb 2009. The 
study was conducted to find out the extraction parameters of polysaccharide from Portulaca 
oleracea L. (POP) and the antidiabetic activity of POP on alloxan induced diabetic mice using 
single factor test. The study revealed that the polysaccharide extracted from Portulaca 
oleracea L. can control blood glucose and modulate the metabolism of glucose and blood 
lipid in diabetes mellitus mice. 
 
 
3. Hee Yun et al., (2009). Insulin increase glucose transport in C2C12 Myotubes and HepG2 
cells via activation of AMP-Activated Protein Kinase and Phosphatidylinositol 3-Kinase 
Pathways. J Med Food, volume 12, issue 5, pages 1023-1028, Oct 2009. The study was 
performed to associate the potential health benefits of inulin via AMPK and PI3-K activation. 
Inulin increased the uptake of glucose in C2C12 myotubes, both through AMP kinase and 
Phosphatidylinositol kinase signalling pathways. The results concluded the anti-diabetic 
activity of inulin through AMPK and PI3-K activation. 
 
4. Han Hong Jin et al., (2009) New Cytotoxic thymol derivatives from Inula helianthus 
aquatica (Compositae family). Acta Botanica Yunnanica, volume 31, issue 2, pages 190-192 
(2009). The study was conducted to show the cytotoxicity on cancer cell lines. The results 
indicated that four thymol derivatives were produced from 95% ethanolic extract of Inula 
helianthus flowers that produced cytotoxicity. 
 
5. Huang Huo Qiang et al., (2007) Seven sesquiterpene lactones from flower of Inula 
helianthus aquatica. Chinese J Experimental Traditional Medical Formulae, volume 83, issue 
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6, pages 2011-2017, 2007. The study was elucidated to investigate the chemical constituents 
of Inula helianthus aquatica flower using various chromatographic techniques subjected to 
spectral analysis. The results indicated that aromaticin, 8-epihelenalin, bigelovin, 6-epi-
desacetylisotenulin, carpesiolin, 2,3-dihydroaromaticin and ergolide were produced for the 
first time from the say plant. 
 
 
6. Zeggwagh NA et al., (2006). Hypoglycaemic and  hypolipidemic effects of  Inulia  viscosa 
L.aqueous exracts in normal and diabetic rats .J Ethnopharmacol, volume108,issue 2, pages 
223-227 May 2006.The study was designed to examine the hypoglycaemic and 
hypolipidemic activity of Inula viscosa aqueous extract on normal and diabetic rats. In 
normal rats, a significant reduction in blood glucose levels 2 h was observed after a single 
oral administration (p<0.001). Repeated daily oral administration significantly reduced blood 
glucose levels after 4 days of treatment (p<0.01). In diabetic rats, a significant reduction in 
blood glucose levels was observed 1 h after a single oral administration (p<0.001). Repeated 
oral administration reduced blood glucose levels at the 4th day (p<0.001). No change in total 
plasma cholesterol and triglyceride levels was observed after both a single and repeated oral 
administration in both normal and diabetic rats. We conclude that Inula viscosa possess a 
hypoglycaemic but not hypolipidemic activity in normal and diabetic rats. The observed 
hypoglycaemic activity seems to be independent of insulin secretion. 
 
7. Shan JJ et al., (2006). Effect of an antidiabetic polysaccharide from Inula japonica on 
constipation in normal and two models of experimental constipated mice. After 
administration of IJP, the gastrointestinal propulsive rate was increased by 9.79% and 
10.42%, the start time of defecation was shortened by 37.27% and 44.06%, the number of 
faeces increased by 115.4% and 130.8% in normal mice. In fasting-water constipated mice, 
the start time of defecation was shortened by 9.69% and 30.52% by IJP, defecation granules 
raised by 22.09% and 39.53%, wet faeces weights were increased by 23.50% and 39.14% 
compared with the untreated constipated mice. In diphenoxylate-induced mice, the start time 
of defecation was shortened by 25.48% and 28.13%, defecation granules raised by 100.0% 
and 118.0%. 
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8. Mahmood Mosaddegh et al., (2006). Cytotoxic effects of five species of Inula against some 
tumor cell lines. Iranian J Pharm Sciences, volume 2, issue 4, pages 203-208, August 2006. 
Fractions of five Inula extracts belonging to compositae family were evaluated using MTT 
assay for cytotoxicity against various cell lines including CACO 2 (human colon 
adenocarcinoma), MCF 7 (human breast adenocarcinoma), HEPG2 (human hepatocellular 
carcinoma), VERO (green African monkey kidney), and WEHI 164 (balb C mouse 
fibrosarcoma). The results proved that the species, Inula oculus christi showed better 
cytotoxicity. 
 
9. Jun-Jie Shan et al., (2005) Anti-diabetic and hypolipidemic effects of aqueous extract from 
the flower of Inula japonica in Alloxan-Induced Diabetic Mice. The antidiabetic and 
hypolipidemic effects of aqueous-extract from the flower of Inula japonica and its two 
fractions (IJR and IJP) were investigated in alloxan-induced diabetic mice. An oral glucose 
tolerance test (OGTT) of IJ was also performed in normal and diabetic mice. The results 
showed that IJ (1000 mg/kg), IJR (500 mg/kg) and IJP (250 mg/kg) significantly reduced 
blood glucose levels in diabetic mice by oral administration (p_0.01). IJ and IJP markedly 
decreased serum triglyceride concentrations (p_0.05) in diabetic mice. Their hypoglycemic 
activities were better than gliclazide (40 mg/kg) and compared with metformin (250 mg/kg). 
IJ raised plasma insulin levels in alloxan-induced diabetic mice. 
 
 
10. Gholap S et al.,(2004) Inula racemosa,  Boerhaavia diffusa and Ocimum sanctum (Holy 
Basil) exhibited anti-peroxidative , hypoglycemic and cortisol lowering activities- Green 
Medinfo Summary. Pharmazie, volume 59, issue 11, pages 876-878 (2004). The study 
performed proved that the hypoglycaemic effects of certain plant extracts are mediated 
through inhibition in corticosteroid concentration. 
 
11. Liqun Rao et al., (2011) Optimization of the technology of extracting water soluble 
polysaccharides from Morus alba L. leaves. African Journal of Biotechnology, volume 10, 
issue 59, pages 12714-20, October 2011. The study was carried out to optimize the 
parameters for water soluble polysaccharides from mulberry leaves using hot water extraction 
by orthogonal test through single factor experiment. The results indicated the following 
extraction conditions such as material concentration equivalent to 1:24, an extraction 
CHAPTER-2                                                                                        LITERATURE REVIEW 
 
Department of Pharmaceutical Chemistry, Nandha College Of Pharmacy, Erode Page 24 
 
temperature of 70° C, an duration of 90 minutes and a concentration of ethanol equivalent to 
80% which gave a maximum polysaccharide yield. 
 
 
12. Nathalie M Delzenne et al., (2007) Modulation of Glucagon like Peptide 1 and Energy 
metabolism by Inulin and Oligofructose Experimental data. Journal of Nutrition, volume 137, 
issue 11, pages 2547-51, 2007. The present work depicted the modulation of oligo fructose in 
animal models. The results proved that glucagon like peptide 1 can exert antidiabetic 
properties. It could also modulate other gastro intestinal peptides involved in the control of 
food intake. 
 
13. Jia xian Zhu et al., (February 2012) Chemical Constituents from the Aerial parts of Inula 
japonica Thunb. Natural Product Research and development, volume 23, issue 6, pages 999-
1001, 2012. This was carried out to demonstrate the isolation and purification of ten 
compounds from Inula japonica for the first time using column chromatography. The 
compounds elucidated were ayapin, 7-hydroxycoumarin, daphnetin, citrusin, wedelolactone, 
scopoletin, medioresinol, syringic acid, vanillic acid and isovanillic acid. 
 
 
14. Yang Zhenmin et al., (2011) Isolation and quantitative determination of inulin type 
oligosaccharide in roots of Morinda officinalis. Carbohydrate Polymers: Elsevier, volume 8, 
issue 4, pages 1997-2004, 2011. Based on size exclusion chromatography, inulin type 
oligosaccharides with different degrees of polymerization were isolated followed by 
determination of purity using HPLC- ELSD. The study was performed to analyse 
monosaccharide and oligosaccharide in three types of roots of M. officinalis and provides a 
new basis of assessment on quality of M. officinalis. 
 
15. Hokputsa Sanya et al., (2004) Water soluble polysaccharides with pharmaceutical 
importance from Durio zibethinus: isolation, fractionation, characterization and bioactivity. 
Carbohydtrate Polymers: Elsevier, volume 56, issue 4, pages 471-81, 2004. The activity was 
performed to study the relationship of chemical features of various polysaccharide fractions 
that had been isolated from Durio zibethinus by hot water extraction and alcohol 
precipitation. The physical features of fractionated segments were analysed by size exclusion 
chromatography coupled to multi angle laser light scattering. 
CHAPTER-2                                                                                        LITERATURE REVIEW 
 
Department of Pharmaceutical Chemistry, Nandha College Of Pharmacy, Erode Page 25 
 
16. Sylvia Czapla et al., (2000) Transgenic potato (Solanum tuberosum) tubers synthesize the 
full spectrum of inulin molecules naturally occurring in globe artichoke (Cynara scolymus) 
roots. Proc.Natl Acad Sci, volume 97, issue 15, pages 8699-8704, 2000. The work was 
performed to show that the synthesis of inulin molecules of all chain lengths naturally 
occurring in a given plant species can be produced in planta by means of various enzymes. 
 
17. Gholap S et al., (2003) Effects of Inula racemosa root and Gymnema sylvestre leaf extracts 
in the regulation of corticosteroid induced diabetes mellitus: involvement of thyroid 
hormones. Pharmazie, volume 58, issue 6, pages 413-5, 2003. The above study evaluated the 
individual and combined efficacy of Inula racemosa root and Gymnema sylvestre leaf extract 
in corticosteroid induced hyperglycaemia. The results indicated that the combination was 
more effective than the individual extracts but no changes were seen in the thyroid hormone 
concentrations and therefore not effective for the same, but for steroid induced diabetes 
mellitus. 
 
 
18. Gaafar A M et al., (2010) Extraction conditions of Inulin from Jerusalem Artichoke tubers 
and its effects on Blood glucose and Lipid Profile in diabetic rats. Journal of American 
Science, volume 6, issue 5, pages 36-43, 2010. The analysis for the contents of tubers of 
Jerusalem artichoke was aimed and optimising the conventional extraction of inulin using 
various factors like time extract, temperature, solvent ratio. Accordingly the maximum yield 
was obtained by using a sample to solvent ratio of 1:5 w/v at 80° C for about 90 minutes. 
Also a high level of inulin 15% led to amore reduction of blood glucose level. 
 
19. Thomas Barclay et al., (2010) Inulin – a versatile polysaccharide with multiple 
pharmaceutical and food chemical uses. J Excipients and Food Chem, volume 1, issue 3, 
pages 27-50, 2010. The authors proclaim about inulin, a natural plant derived polysaccharide 
with intense range of food and pharmaceutical applications. It also shows about inulin’s 
physicochemical properties that bestow it with many pharmaceutical applications. 
 
 
20. Greg Kelly et al.,. (2008) Inulin type Prebiotics-A Review Part I. Alternative Medicine 
Review, volume 13, issue 4, pages 315-30, 2008. The article is a review part of inulin type 
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prebiotics which are a group of compounds joined together by the ability to promote the 
growth of specific beneficial gut bacteria. 
 
21. Holownia Piotr et al., (2010) The benefits and potential health hazards posted by the 
prebiotic Inulin- a Review. Pol J.Food Nutr. Sci, vol 60(3):201-11 (2010). The work 
demonstrated that inulin prebiotic is a non digestible carbohydrate normally occurring 
through out the normal human diet. The most beneficiary effects to human health are 
maintenance of microbial gut homeostasis, reduction in gut inflammation, prevention of 
colonic cancer, increase in mineral absorption, and decrease in cholesterol and bowel level 
improvements. The ultimate aim was to discuss the scientific evidence and to address the 
general concerns of consumers. 
 
 
22. Hariono Maywan et al., (2009) Extraction, identification and acetylation of inulin from 
Dahlia tubers. The 9
th
 national Symposium on Polymeric materials: Pages 572-9, 2009. The 
study depicts the acetylation of inulin in polar aprotic organic solvents such as pyridine and 
dimethyl formamide. The results showed that the yield produced using pyridine presented 
40% and this method was a preferable way to graft the inulin backbone with acetylation. 
 
23. Ll He et al., (2012) Research Progress on polysaccharides from Ginkgo biloba. Journal of 
Medicinal plants and Research, volume 6, issue 2, pages 171-6, 2012. The present activity 
was conducted to prove that Ginkgo biloba polysaccharides reduce blood sugar, immune 
regulation, anti oxidation, anti inflammatory effects. The extraction was carried out using ht 
water extraction and alcohol precipitation. The extracted methods were then purified using 
step by step precipitation, salting out and column chromatography. 
 
 
24. Narindoe Kaur et al., (2002) Applications of Inulin and oligo fructose in health and 
nutrition. J Biosci, volume 27, issue 7, pages 703-14, 2002. The work was extended to prove 
the extensive health promoting applications of inulin and oligo fructose in various lines, both 
pharmaceutically and biologically. 
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PLANT PROFILE 
FIGURE    3.1 
INULA HELIANTHUS AQUATICA PLANT 
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3.1 PLANT PROFILE 
SCIENTIFIC NAME:  Inula helianthus aquatica 
SYNONYMS            :  Aquatic Sunflower 
FAMILY                  :  Asteraceae 
COMMON NAME    :  1) Chinese  : Shui chao yang cao 
                                         2) Tamil  :   Kaattu   sooryakanthi 
                                         3) Malayalam :  Kaattu sooryakanthi 
Inula is a large genus of about 90 species of flowering plants in the family Asteraceae, 
native to Europe, Asia and Africa.  
They are mostly perennial herbs that vary greatly in size, from small species a few 
centi meters tall to enormous perennials over 3 meters tall. Some common characteristics 
include pappus with bristles, flat capitalum, and lack of chaff. Several species are popular 
flowers for the garden, with cultivation going back to antiquity. The name Inula was already 
used by the Romans and derived from Helen of Troy fame.  
Inula helianthus aquatic is found in parts of south west of China , in India ita found in 
Kerala, Maharashtra, Gujarat, it is a wild plant, but it cultivated  also as ornamental plant. 
3.2 PARTS USED: 
 Flowers and Leaves 
3.3 DESCRIPTION 
   Inula helianthus aquatica belonging to the Asteraceae family is characterised by 
many small flowers, arranged in a head looking like a single flower and subtended by an 
involucres of bracts .The head may consist of both ray flowers and disk like flowers as in 
sunflower. 
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It grows about2 meters long. it is a annual plants stem is leafy smooth and greenish 
and middle  leaf densely, 2.5-4.5*2-3cm, with ovate base chordate and amplexicaul. 
Coloured leaves arranged into alternate phyllotaxy and reticulate venation. Margin coarsely 
serrate and apex rounded. 
3.4 PROPERTIES AND MEDICINAL USES 
Inula helianthus aquatica was traditionally used for different ailments in Chinese and in 
Ayurveda.  The entire plant is used and is considered acrid, sweet, and warm. It expels wind-
dampness, mend sinew and bone, stop bleeding, and resolve toxin. It is used for wind-
dampness pain, broken bones, external injury with bleeding, and clove sores with toxic 
swelling. Seeds used for optic disorder and pitha and kapha treatment in ayurveda, it is 
denoted in the book of bavaprakeshnighudu.  It possess anti-tumour, anti-diabetic, anti-
inflammatory, anti- ulcer, anti-oxidant properties.
2,54 
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SCOPE OF WORK 
The world has an approximate estimation of 300-350 millions of people with type II 
diabetes. Diabetes mellitus is becoming more prominent and wide spread due to the changes 
in life style and food habits   and due to genetic variation. It causes defects in protein, lipid 
and carbohydrate metabolism, resulting in an increase in the incidence of related diseases 
such as cardio vascular disorders, renal disorders, even affects brain and the central nervous 
system, finally impairing functions of almost all organs in the body. About 400- 500 species 
of plants were identified as anti-diabetic and many have hypoglycaemic effects exerted by 
different mechanisms of action. Very few have been introduced into the modern system, 
despite their roles in traditional systems such as Ayurvedic and Chinese systems. 
Inula helianthus aquatica belonging to the Asteraceae family is widely used in the 
Chinese medicine and also in Ayurveda. It possess anti-tumour, anti-diabetic, anti-
inflammatory, anti- ulcer, anti-oxidant properties. The entire plant is used and is considered 
acrid, sweet, and warm. It expels wind-dampness, mend sinew and bone, stop bleeding, and 
resolve toxin. It is used for wind-dampness pain, broken bones, external injury with bleeding, 
and clove sores with toxic swelling. It also possess anti-ulcer, anti-inflammatory, anti- 
tumour, anti-epileptic, anti-helminthic, anti-septic, anti-tussive, cardiotonic, diuretic, 
diaphoretic and analgesic properties. 
The present study was done to standardise Inula helianthus aquatica and to evaluate 
the anti-diabetic potential with its mechanism of action. The anti-diabetic property was 
validated by correlating various biochemical parameters. 
4, 25, 40 
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PLAN OF WORK 
  The study was carried into five various sections as follows. 
A. PHYTOCHEMICAL ANALYSIS: 
a) Collection and authentication of the plant Inula helianthus aquatica. 
b)  Extraction of active constituents from leaves of Inula helianthus aquatica by hot   
water extraction using reflux and continuous hot percolation by using Hexane, 
Ethanol and Water. 
c) Determination of phyto constituents present in the 3 extracts. 
 
B. ISOLATION OF ACTIVE CONSTITUENTS FROM LEAVES OF INULA    
HELIANTHUS AQUATICA: 
            The extraction process was carried out using Soxhlet extraction and reflux 
condensation at a pre-determined temperature setting. Appropriate solvent usage contributed 
to a maximum yield of the product. Precipitation technique using alcohol was used to bring 
about the separation of the final product followed by the quantitative calculation of the 
collected net content. 
C. PHARMACOLOGICAL EVALUATION OF LEAVES OF INULA    
HELIANTHUS AQUATICA: 
a) Anti-diabetic evaluation 
1. Alloxan induced diabetes on rats 
 
D. BIOCHEMICAL PARAMETER FOR ANTI DIABETIC ACTIVITY: 
a) Serum glucose 
b) Liver function test 
1. Serum Glutamate Oxaloacetate Transaminases (SGOT) 
2. Serum Glutamate Pyruvate Transaminases (SGPT) 
3. Alkaline Phosphatase (ALP) 
 
E. STATISTICAL ANALYSIS: 
The analysis was carried out using graph pad prism software. The collected data was 
subjected to appropriate statistical test including one way ANNOVA, followed by an 
appropriate Dunnett’s t-test. 
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PRELIMINARY PHYTOCHEMICAL   STUDIES 
 
6.1 MATERIALS AND METHODS 
6.1.1 Collection and authentication of plant material 
             The plant Inula helianthus aquatica belonging to the family Asteraceae 
(Compositae), is found throughout the parts of India, south west China, and other south east 
Asian countries, Africa and some parts of Europe. The plants were collected from parts of 
Malappuram District of Kerala. It was identified and confirmed by botanist. 
6.1.2. Animal approval 
 The study was conducted after obtaining the approval from Institutional Animal 
Ethics Committee (IAEC), and the experimental procedure were in accordance to the 
guidelines of IAEC (No:688/02/c/CPCSEA). 
6.2 PREPARATION OF EXTRACTS 
          Preparation of the different extracts of the powdered leaves of Inula helianthus 
aquatica was carried out successively by hot water reflux and by continuous hot percolation 
method by using the following reagents. The defatted leaves with petroleum ether and were 
extracted by using the following reagents 
6.2.1 HEXANE EXTRACT 
       Hexane extraction was carried out by extracting powdered leaves of Inula helianthus 
aquatica with hexane. The powdered leaves about 250 gm is packed well in a soxhlet 
apparatus and extracted with hexane (60-75
°
C), until colour of solvent is retained in it’s 
original form in the siphon tube. The extract was filtered while hot and vacuum distilled and 
dried in desiccators. It was dried and percentage was calculated. 
6.2.2 ETHANOL EXTRACT 
          After the Hexane extraction, the marc obtained was taken out and air dried, again 
packed in soxhlet apparatus and extracted with Ethanol, until extraction was complete. It was 
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then  filtered  and   distilled ,  in  reduced   pressure  and  dried  in  desiccators . The extract 
was weighed and percentage yield was calculated. 
6.2.3. AQUEOUS EXTRACT 
30, 32, 33, 43, 44, 49 
      Polysaccharides are polar macromolecular compounds and the method of hot water 
extraction and alcohol precipitation using reflux condensation was used for the extraction of 
polysaccharides. In the above method, often a portion of the residual protein would be 
removed and a suitable reagent that brings about polysaccharide precipitation was 
complemented towards the finalising stage. The temperature and the duration of the 
extraction procedure were determined using investigational studies. An aliquot portion of the 
collected sample was transferred to a high grade round bottom flask and continuously 
refluxed for a calculated time period of three hours at a pre-determined extraction 
temperature of 60-70
°
C. Subsequently, alcohol precipitation was followed (using various 
concentration) and the precipitate obtained was redissolved in water and the polysaccharide 
content was determined.
 
                                        
TABLE 6.1 
 
Data for successive extraction values of various extracts of leaves of Inula helianthus 
aquatic. 
 
SI NO. EXTRACTS %YEILD(W/W) 
1 Hexane extract 3.7 % 
2. Ethanol extract 4.5 % 
3 Aqueous extract 3.4 % 
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FIGURE 6.1  
AQUEOUS EXTRACTION 
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6.3 QUALITATIVE PHYTOCHEMICAL ANALYSIS 
The Hexane, Ethanol, and Aqueous extracts of Inula helianthus aquatica were subjected to 
various phyto chemical tests, for detecting the presence of various chemical constituents that 
might be present in that plant. 
6.3.1 TEST FOR ALKALOIDS 
Aliquot portion of the plant extract was acidified with few ml of Hydrochloric acid and the 
resulting solution was used for performing the test for Alkaloids. 
a. Dragendroff’s Test: The extract was treated with few drops of Dragendroff’s reagent. 
(Potassium Bismuth Iodide solution). Orange coloured spots indicated the presence of 
alkaloids). 
b. Hager's Test: The extract was treated with a few ml of Hager's reagent (Saturated 
Solution of Picric Acid) and a yellow precipitate was produced showing the presence of 
alkaloids. 
c. Wagner's Test: The extracts were treated with aliquot quantities Wagner's reagent    
(Iodine-Potassium Iodide). Reddish brown precipitate indicated the presence of 
alkaloid. 
d. Mayer’s Test: Extract gives cream colour precipitate with Mayers reagent (Potassium 
Mercuric Iodide solution).         
6.3.2 TEST FOR SAPONINS 
  The following tests of saponins were carried out: 
a. Foam Test: 1 gm of extract was with diluted with 20 ml distilled water in graduated 
cylinder and shaken for 15 minutes. A foam layer of 1cm indicated the presence of 
saponins. 
b. Hemolysis Test: Saponins produces hemolysis of red blood cells 
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6.3.3 TEST FOR GLYCOSIDES 
a. Legal’s Test: About 0.1gm of the extract was treated with pyridine (2ml) and added 
sodium nitro prusside solution (2 ml) and made alkaline with sodium hydroxide 
solution (pink to red colour solution indicated the presence of glycosides). 
b. Keller-Killiani Test: Extract with chloroform mix well and evaporated it to dryness. 
Add 0.4 ml of glacial acetic acid containing trace amount of ferric chloride. Transfer to 
a small test tube, added carefully 0.5 ml of concentrated sulphuric acid by the side of 
the test tube. Acetic acid layer shows blue colour. 
c. Raymond Test: When the extract was treated with hot methanolic alkali, a violet 
colour is produced. 
d. Baljets Test: Extract with picric acid or sodium picrate, orange colour is produced. 
6.3.4 TEST FOR CARBOHYDRATES 
a. Molisch's Test: A small quantity (300 mg) of the extract was dissolved in 4 ml distilled 
water and filtered. The filtrate was subjected to Molisch’s test (Formation of reddish 
brown ring indicated presence of carbohydrate). 
b. Fehling's Test: Dissolved a small portion of extract in water and treated with Fehling's 
solution. (Brown colour indicated the presence of carbohydrate). 
c. Benedict’s Test: Extract solution about 1ml is added to 5ml of benedict’s reagent and 
boiled for 2 minutes and cooled. A red precipitate is produced. 
d. Selivnoff’s Test: To a few ml of extract solution, add about 2ml of Selivanoff’s reagent 
ketohexose which forms a deep red colour when reacted with Seliwanoff's reagent. An 
aldo hexose, will show a light pink colour that takes a longer time to develop when 
reacted with Seliwanoff's reagent.  
e. Iodine test for Polysaccharides: Polysaccharides react to a lesser with iodine to form a 
red-brown or reddish-purple colour. 
6.3.5 TEST FOR PHENOLIC COMPOUNDS AND TANNINS   
a. Braemer's Test: To a 2-3 ml of extracts, 10% alcoholic ferric chloride solution was 
added. (Dark blue or greenish grey coloration of the solution indicated the presence of 
tannins). 
 
CHAPTER -6                                               PRELIMINARY PHYTOCHEMICAL STUDIES 
 
Department of Pharmaceutical Chemistry, Nandha College Of Pharmacy, Erode Page 37 
 
6.3.6 TEST FOR PROTEINS AND AMINO ACIDS 
a. Ninhydrin Test: Dissolved a small quantity of extract in a few ml of water and 
subjected to ninhydrin. (Blue coloration indicated the presence of amino acids). 
b. Biuret Test: Extract added to Biuret reagent and a violet colour indicates the presence 
of proteins. 
6.3.7 TESTS FOR FLAVONOIDS 
a. Shinoda Test: To 2-3 ml of extract, a piece of magnesium ribbon and l ml of 
concentrated hydrochloric acid was added. (Pink red or red coloration of the solution 
indicated the presence of flavanoids). 
b. Lead Acetate Test: To 5 ml of extract solution added l ml of lead acetate solution. 
(Flocculent white precipitate indicated the presence of flavanoids). 
6.3.8 TEST FOR STEROIDS / TERPENOIDS 
a. Libermann - Burchard Test: To l ml of extract, l ml of chloroform followed by 2-3 ml 
of acetic anhydride, and 1 to 2 drops of concentrated sulphuric acid were added.  (Dark 
green coloration of the solution indicated the presence of steroids and dark pink or red 
coloration of the solution indicated the presence of terpenoids). 
b. Salkowski Test: Extract was treated with few drops of concentrated sulphuric acid. Red 
colour at lower layer indicates that the presence of Steroids and formation of yellow 
colour at lower layer indicates presence of triterpenoids. 
6.3.9 TEST FOR FIXED OILS AND FATS 
Press small quantities of latex extract between two filter papers. Oil stains on the 
paper indicated that the presence of fixed oils.  
6.4 RESULT AND DISCUSSION 
The leaves of Inula helianthus aquatica was extracted with various solvents like 
Hexane, Ethanol, Water and subjected to preliminary phyto chemical screening for the 
presence of different chemical groups. 
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TABLE 6.2  
Data for qualitative Phytochemical analysis of various extract of Inula helianthus 
aquatica leaves. 
Present (+) Absent (-) 
 
PHYTOCONSTITUENTS 
HEXANE  
EXTRACT 
ETHANOL 
EXTRACT 
AQUEOUS 
EXTRACT 
ALKALOIDS - + - 
CARBOHYDRATES - - + 
FIXED OILS AND FATS + - - 
FLAVONOIDS - + + 
GUMS AND MUCILAGE - + + 
GLYCOSIDES - + + 
PROTEINS AND AMINO ACIDS - - - 
SAPONINS - - - 
STEROIDS + + - 
TERPENOIDS + + - 
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 ISOLATION AND CHARACTERIZATION 
Inula helianthus aquatica (Asteraceae) is an important member of the species Inula. The 
species is rich in polysaccharides such as Inulin, which constitute majority of the oligofructoses, 
mainly responsible for the hypoglycemic effect. Inulin and inulin like Oligo fructoses, functional 
food ingredients found in various edible plants, has been reported to exert potential health 
benefits, including decreased risk of colonic diseases, non–insulin-dependent diabetes, obesity, 
osteoporosis, and cancer etc. Several methods such as TLC, HPTLC, GSC, HPLC, etc can be 
used for the isolation of oligofructoses, such as Inulin. 
7.1. CHROMATOGRAPHIC STUDIES 
These are some of the preliminary and common analytical techniques, used for the 
purification and separation of organic and inorganic substances. 
7.1.1 THIN LAYER CHROMATOGRAPHY
50
 
Thin layer chromatography is described as a method for chromatographic analysis on thin 
layers of adsorbents. The technique is rapid and helps in the separation of micrograms of the 
substances. 
Some  workers  refer  this  technique  as  open  column  chromatography , spread  layer 
chromatography and  surface  chromatography. 
Though thin layer chromatography is similar to paper and column chromatography, but it 
is considered to be far superior to both of them because of the certain specific reasons. 
a. Separation is sharpest as compared to paper and column chromatography. 
b.  It requires less time and less amount of substance. 
c. Acid is directly sprayed on TLC plates as identifier. 
d. Individual spots are less diffused as compared to paper chromatography. 
e. Plates can be heated to high temperature without causing damage. 
f. Several coating substances can be used, such as alumina, silica gel, and cellulose. 
g. The capacity of thin layer of an adsorbent is higher than that of paper. 
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h.  It is easy to coat the paper with variety of corrosive reagents that would destroy the paper. 
7.1.2 BASIC OPERATIONS INVOLVED 
a. Preparation of chromatographic plates. 
b. Application of samples to chromatographic plates. 
c. Choice of adsorbent. 
d. Selection of solvent. 
e. Proper developing system. 
f. Location of compounds on chromatographic plates. 
g. Detection and identification. 
The aqueous extract of leaves of Inula helianthus aquatica leaves shown a clear spot on 
thin layer chromatographic plate with the solvent system containing, glacial acetic acid 
:chloroform: water(7:6:1). Detected by spraying with Aniline-Diphenylamine reagent, a deep 
browinsh colored spot was produced.
3 
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FIGURE 7.1  
Photo of TLC plate showing spot of aqueous extract. 
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7.2.1 COLUMN CHROMATOGRAPHY 
51 
  Column chromatography is defined as the uniform percolation of a liquid through a 
column of finely divided substances. The selected substances selectively retard certain 
components of the liquid. 
The interaction of a substance with the stationary phase may occur in several ways. 
 There may be direct interaction between the substance and the surface of the phase. 
 The stationary phase may merely hold a second fluid phase so that the distribution 
involves a partition between two liquid phases. 
 This method been used successfully in many complicated systems and is not limited to 
colored solutions only. For each type there are definite disciplines which are taken into 
considerations. 
 The important things to be considered are types of solvents, adsorbents, design of the 
apparatus and the nature of the substance to be identified. The rate of flow of solvent is increased 
or decreased depending on the viscosity and other factors. 
7.2.1.1 REQUIREMENTS OF COLUMN CHROMATOGRAPHY 
Adsorbent used   :Silica gel (column grade 60-120) 
  Eluent    :Chloroform to Water in gradation 
 Length of column   :60cm 
 Diameter of column   : 3.5cm 
 Quantity of aqueous extract : 5gm 
 Length of column packed  :40cm 
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7.2.1.2 PROCEDURE 
 Column preparation 
 Column was dried and a glass wool was plugged to its bottom. Then a layer of sand bed 
was placed over the glass wool, to give a flat level. After that the column grade silica gel was 
poured slowly into the column. It was allowed to stand for some time. 
 Aqueous extract of Inula helianthus aquatica was kept over the layer of adsorbent, with a 
layer of paper disc and sand bed over the adsorbent that prevents any disturbance of the 
adsorbent layer. 
 Development of chromatograph 
 Column work was done by adding the aqueous extract of Inula helianthus aquatica over 
the column grade silicagel 60-120 mesh.The process was carried out using solvents in the 
increasing order of polarity, including Benzene,Chloroform, Water. 
 About 25 ml of the fractions were collected and evaporated to get the residue, and tested 
for the presence of different constituents, by thin layer chromatography. Chloroform :water 
(85:15) gave single  spot on TLC . It was confirmed by characterization using IR, NMR and 
MASS. 
9, 17, 30, 50 
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TABLE 7.1   
 Data for column chromatography 
Fraction Solvent Ratio 
Nature of 
residue 
Analysis by TLC 
1-5 Benzene 100 No residue No spot 
16-25 
Benzene: 
Chloroform 
85:15 Yellow Merged spot 
26-35 
Benzene: 
Chloroform 
50:50 Greenish yellow Merged spot 
47-60 
Chloroform: 
Water 
85:15 Brown Single spot 
60-72 
Chloroform: 
Water 
50:50 Brownish yellow Two distinct spot 
 
 Chemical characterization of the isolated compound  
47-60
th
   fractions of Chloroform: Water solvent system was treated with 0.5ml of Hydrochloric 
acid and heated for 2 minutes, cooled and neutralized to litmus paper with 5M Sodium 
hydroxide. Added 5ml of cupric-tartaric acid solution and heated.  A red precipitate was 
produced which conforms the presence of Oligo Fructose.
3 
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FIGURE NO. 7.2 
IR Spectrum of isolated fraction 
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TABLE NO. 7.2 
IR Interpretation of the isolated fraction: 
 
  Sr. No:                    Functional groups  Wave number (cm
-1
) 
     1.                Aliphatic OH stretching  3639.80  
      2.                Aliphatic C-H stretching    2875.96 
      3.                Aliphatic C-H stretching  2849.92 
      4.                Ether C-O-C    stretching 1260.52 
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FIGURE NO. 7.3 
NMR Spectrum of isolated fraction 
 
NMR Interpretation of the isolated fraction:  
2.1 (2H of  CH2 ),  4.8 (4H of tetrahydro furan, m), 4.2 (1H of OH), 3.2 (2H of OCH2) 
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FIGURE NO. 7.4 
MASS Spectrum of isolated fraction 
 
MASS Interpretation of the isolated fraction: 
Mass: 662.523(M+) 
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EVALUATION OF ANTIDIABETIC ACTIVITY 
8.1 INTRODUCTION 
Diabetes mellitus is a metabolic disorder in the endocrine system. This dreadful disease is 
found in all parts of the world and is becoming a serious threat to mankind health. There are lots 
of chemical agents available to control and to treat diabetic patients, but total recovery from 
diabetes has not been reported up to this date. Alternative to these synthetic agents, plants 
provide a potential source of hypoglycemic drugs and are widely used in traditional systems of 
medicine to prevent diabetes. Several medicinal plants have been investigated for their beneficial 
uses in different types of diabetes. The effects of these plants may delay the effect of diabetic 
complications and correct the metabolic abnormalities using variety of mechanisms. 
8.2 MATERIALS AND METHODS 
8.2.1 Selection of animals 
Male albino rats of Wistar strain and weighing about 100-200 gm were used for the 
study. The animals were got from Nandha College of pharmacy and research institute, Erode, 
and were approved by Ethical committee (NCP/IAEC/PG-2010/20). 
8.2.2 Maintenance of animals 
The animal house was well ventilated and animals had 15-20 ±2
O
C. The animals were 
housed in large spacious hygienic cages during the course of the experimental period. 
The animals were fed with rat pellets feed supplied by M/s Hindustan Lever Limited, 
Bangalore, India and filtered water and lithium. Animals described as fasted were deprived of 
food for ≥16 hr but allowed free access to water. The place where the experiments were 
conducted was kept very hygienic by cleaning with antiseptic solution, as the diabetic animals 
are susceptible to infections. 
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8.2.3 Chemicals  
1. Alloxan monohydrate(Sigma chemicals, Bangalore) 
2. Diethyl ether (Nice chemicals, cochin) 
3. Carboxy methyl cellulose 
4. Carbon tetra chloride (Nice chemicals, cochin) 
8.2.4 Drugs 
1. Leaf extract of  Inula helianthus aquatica 
2. Glibenclamide 5mg/kg 
8.3 PROCEDURE: 
8.3.1 Aqueous Extraction: 
Aqueous extract was prepared from a powder of the leaf extract of Inula helianthus 
aquatica was prepared in an electric grinder. The 200 gm powder was extracted with water. The 
extract was evaporated to dryness under vacuum and dried in vacuum desiccators (5%w/w). 
8.4 EXPERIMENTAL DESIGN: 
Different groups of rats were used to study the effect of aqueous extract of Inula 
helianthus aquatica. The rats were divided into five groups each consisting of six rats: 
Group 1: The rats received 2 ml CMC. These animals serve as normal controls. 
Group 2: Received a single dose of (150mg/kg body weight), Alloxan monohydrate in 
CMC through intraperitoneal route and served as negative control. 
Group 3: Received the aqueous leaf extract 200mg/kg for 21days and served as test 1. 
Group 4: Received the leaf extract 400mg/kg for 21 days and served as test 2. 
Group 5: Received Glibenclamide 5mg/kg for 21days and served as positive   control. 
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8.5 INDUCTION OF DIABETES: 
Animals were allowed to fast 24 hr and were injected with freshly prepared aqueous 
solution of alloxan monohydrate (150 mg/kg i.p.) as reported previously (Kameswara Rao et al., 
1999). After a week rats with marked hyperglycemia (fasting blood glucose>200mg/dl) were 
used for the study. 
8.6 DETERMINATION OF BLOOD GLUCOSE: 
Blood glucose was collected for the measurement of blood glucose from the tail vein at 0, 
1, 2 and 3 hr after feeding the plant extracts. The blood glucose levels were determined by using 
one touch glucometer. 
8.7 BIOLOGICAL ESTIMATION: 
After the experimental regimen, the blood is collected through the retro-orbital puncture 
of eye of animals under mild diethyl ether anesthesia in Eppendorff’s tube (1ml) containing 50µl 
of anticoagulant (10% trisodium citrate) and the serum was separated by centrifuging at 6000rpm 
for 15min. the biochemical parameters, cholesterol, triglycerides, total protein, SALP, SGOT and 
SGPT are determined by using the commercial kit available ( Ecoline, manufactured by Merck 
Specialities private limited, Ambernath.) 
8.8 STATISTICAL ANALYSIS: 
The collected data were subjected to appropriate statistical test including one way 
ANOVA, followed by an appropriate Dunnett’s t-test, P-value of less than 0.05, 0.01 and 0.001 
were considered as less significant, significant and more significant respectively. The analysis 
was carried out using graph pad prism software. 
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8.9 RESULT AND DISCUSSION: 
Screening of anti hyperglycemic activity of extracts in Alloxan induced diabetic rats. 
The effect of  Inula helianthus aquatica, leaf extract on fasting blood glucose level in 
alloxan induced diabetic rats were give in Table8.1 and Graph 8.2. The lower dose of root extract 
200gm/kg produced a slight decrease in fasting blood glucose level on the 28
th
 day, when 
compared with diabetic controlled animal. The higher dose of leaf extract, 400mg/kg produced a 
less significant reduction (P<0.05) from the 14
th
 day and a significant reduction (p<0.01) from 
21
th
 days treatment the leaf extract was found to be more potent at the higher dose, 400mg/kg 
and it brought down the elevated blood glucose level in alloxan induced diabetic rats nearer to 
the normal range. 
29,31,34,37,41,42
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TABLE 8.1 
The effect of aqueous leaf extract of Inula helianthus aquatica on fasting blood glucose level 
in Alloxan induced diabetic rats. 
 
 
GROUPS 
 
1
st
Day 
 
1
st
week 
 
2
nd
 week 
 
3
rd
 Week 
 
CMC (0.5 %) 
 
 
88.5±3.81 
 
98.33±6.41 
 
105.33±5.28 
 
101.33±2.82 
Diabetic control 
(150 mg/kg 
ALLOXAN) 
 
135±7.41 
 
255±6.85 
 
274.16±6.11 
 
289±6.53 
 
Test-I( Aq. extract 
-200mg/kg) 
 
105.83±6.93** 
 
161.83±8.75** 
 
158±8.87** 
 
135.5±3.21** 
 
Test-II (Aq. 
extract -
400mg/kg) 
 
102.83±6.93** 
 
154.66±5.06** 
 
143.16±4.36** 
 
123.66±5.73** 
 
Standard 
(Glibenclamide)  
(5mg/kg) 
 
104.17±4.57** 
 
143.16±7.09** 
 
135.33±5.92** 
 
131±3.48** 
 
Data represents mean ± S.D(n=5) 
*p˂0.05 significant as compared to normal control. 
**p˂0.01significant as compared to   Alloxan control. 
***p˂0.01 significant as compared to Alloxan control. 
ns is non significant as compared to normal control. 
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FIGURE 8.1 
Effect of aqueous leaf extract of Inula helianthus aquatica on fasting blood glucose level in 
Alloxan induced diabetic rats 
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TABLE 8.2 
Effect of aqueous extract of leaves of Inula helianthus aquatica on cholesterol 
 
 
       **p˂0.01significant as compared to Alloxan control. 
 
 
 
 
 
 
 
 
 
GROUPS CHOLESTEROL (mg/dl) 
Normal control (0.5% CMC) 
 
105±1.62 
Diabetic control (150mg/kg ALLOXAN) 
 
133.33±1.49 
Test-I(  Aq. extract  -200mg/kg) 
 
127±1.29** 
Test-II Aq. extract -   400mg/kg) 
 
115.66±2.31** 
STANDARD DRUG(5mg/kg) 
 
100.66±1.33** 
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FIGURE 8.2 
Effect of aqueous extract of leaves of Inula helianthus aquatica on cholesterol. 
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TABL 8.3 
Effect of Aqueous extract of leaves of Inula helianthus aquatica on Triglycerides 
 
 
 
GROUPS TRIGLYCERIDES (mg/dl) 
Normal control (0.5% CMC) 
 
75.166±1.16 
Diabetic control (150mg/kg    ALLOXAN) 
 
104.5±1.54 
Test-I(Aq. extract -200mg/kg) 
 
96.16±1.01** 
Test-II (Aq. extract- 400mg/kg) 
 
82.5±0.76** 
STANDARD DRUG(5mg/kg) 
 
82.16±1.19** 
    **p˂0.01significant as compared to   Alloxan control. 
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FIGURE 8.3 
Effect of Aqueous extract of leaves of Inula helianthus aquatica on Triglycerides 
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TABLE 8.4 
Effect of Aqueous extract of leaves of Inula helianthus aquatica on total proteins 
 
 
   *p˂0.05 significant as compared to normal control. 
   **p˂0.01significant as compared to   Alloxan control. 
 
 
 
 
 
 
 
GROUPS TOTAL PROTEIN (g/dl) 
Normal control (0.5% CMC) 
 
7.5±0.42 
Diabetic control (150mg/kg ALLOXAN) 
 
4.33±0.49 
Test-I(Aq. extract -200mg/kg) 
 
5.83±0.30* 
Test-II(Aq. extract -   400mg/kg) 
 
6.16±0.30* 
STANDARD DRUG(5mg/kg) 
 
6.83±0.40** 
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FIGURE 8.4 
Effect of Aqueous extract of leaves of Inula helianthus aquatica on total proteins. 
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TABLE 8.5 
Effect of Aqueous extract of leaves of Inula helianthus aquatica  on   SALP 
 
 
 
   
                     
 
GROUPS SALP (IU/L) 
Normal control (0.5% CMC) 
 
265.50±3.69 
Diabetic control (150mg/kg ALLOXAN) 
 
431.16±0.98 
Test-I(Aq. extract -200mg/kg) 
 
320.33±1.35** 
Test-II(Aq. extract -   400mg/kg) 
 
261±1.46** 
STANDARD DRUG(5mg/kg) 
 
309.16±1.22** 
          **p˂0.01significant as compared to   Alloxan control. 
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FIGURE 8.5 
Effect of Aqueous extract of leaves of Inula helianthus aquatica on SALP 
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TABLE 8.6 
Effect of aqueous extract of leaves of Inula helianthus aquatica   on SGOT 
 
 
 
GROUPS 
SGOT(IU/L) 
Normal control (0.5% CMC) 
 
35.17±2.80 
Diabetic control (150mg/kg ALLOXAN) 
 
89.83±2.81 
Test-I(Aq. extract -200mg/kg) 
 
58±2.16** 
Test-II(Aq. extract -   400mg/kg) 
 
49.83±1.87** 
STANDARD DRUG(5mg/kg) 
 
40±1.77** 
      **p˂0.01significant as compared to Alloxan control. 
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FIGURE 8.6 
Effect of aqueous extract of leaves of Inula helianthus aquatica on SGOT 
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TABLE 8.7 
Effect of aqueous extract of leaves of Inula helianthus aquatica on SGPT 
         
       **p˂0.01significant as compared to Alloxan control. 
 
 
 
 
 
 
 
GROUPS SGPT(IU/L) 
Normal control (0.5% CMC) 
 
67.17±2.44 
Diabetic control (150mg/kg 
ALLOXAN) 
 
110.67±2.57 
Test-I(Aq. extract -200mg/kg) 
 
87.17±2.17** 
Test-II(Aq. extract -   400mg/kg) 
 
65.33±3.67** 
STANDARD DRUG(5mg/kg) 
 
63±2.14** 
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FIGURE 8.7 
Effect of aqueous extract of leaves of Inula helianthus aquatica on SGPT 
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RESULTS AND DISCUSSION 
The plant Inula helianthus aquatica belonging to the family Asteraceae  was selected and 
various studies such as phytochemical and pharmacological activities were carried out. The plant 
was collected from the Malappuram district of Kerala, and was authentified by the botanist for 
confirmation. 
Plant leaves were collected and was shade dried for 20 days, until it was dry enough for 
extraction. It was then powdered in a grinder and extracted with solvents such as hexane, 
ethanol, and water. 
The extracts were subjected to various preliminary phytochemical tests and the results 
indicated the presence of Oligo fructoses, in the aqueous extract as shown in Table No 6.2.  
The compounds were identified by TLC and isolated by column chromatography. 
The spectral studies were carried out from the aqueous extract of Inula helianthus 
aquatica leaves and subjected for purity testing. Then the purified fractions were subjected to IR, 
1- H NMR, MASS, studies for the confirmation of the functional groups, number of protons and 
molecular weight. 
The results demonstrates that the lower dose of leaf extract 200mg/kg produced a slight 
decrease in fasting blood glucose level on the 28
th
 day, when compared with diabetic controlled 
animal whereas the higher dose of leaf extract, 400mg/kg produced a less significant reduction 
(P<0.05) from the 14
th
 day and a significant reduction (p<0.01) from 21
th
 days treatment the leaf 
extract was found to be more potent at the higher dose, 400mg/kg and it brought down the 
elevated blood glucose level in alloxan induced diabetic rats nearer to the normal range.     
The results obtained from the chemical tests, IR, NMR, MASS spectroscopy gave the 
conclusion that Oligo fructoses were present in the extract.  
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The anti-diabetic activity of the aqueous extract of Inula helianthus aquatica leaves were 
compared with that of standard drugs. The aqueous extract of Inula helianthus aquatica leaves 
produced significant anti diabetic activity in dose dependent manner as shown in Table No 8.1. 
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CONCLUSION 
 
The selected plant, Inula helianthus aquatica belonging to the family Asteraceae gave a 
detailed report on preliminary phytochemical, isolation of active constituents and 
pharmacological studies. 
The plant was selected for the work on the basis of its traditional use. Some related 
species have already proven for their anti diabetic activity. The Asteraceae family in general has 
anti-diabetic potential along with anti-ulcer, anti-inflammatory, anti- tumour, anti-epileptic, anti-
helminthic, anti-septic, anti-tussive, cardiotonic, diuretic, diaphoretic and analgesic properties. 
The phyto chemical studies, isolation, and spectral studies were carried out. In the present 
study the aqueous extract of leaves has proven anti-diabetic potential and helps in prevention and 
management of diabetes.  
The anti-diabetic work was done on alloxan induced diabetic rats, and the results 
obtained has proven the potential of anti diabetic properties in aqueous extract of Inula 
helianthus aquatica leaves. 
Detailed studies on the phyto constituents of the plants are yet to be established regarding 
the antidiabetic potential of this plant. 
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